Literature DB >> 16953977

The interferon response to bacterial and viral infections.

Eric M Pietras1, Supriya K Saha, Genhong Cheng.   

Abstract

Type I interferons (IFNs) were first described several decades ago as soluble factors that were capable of 'interfering' with viral replication when added to infected cells. Type I IFNs have been shown to be induced by recognition of viral DNA and RNA via three distinct pathways: (i) a TRIF-dependent pathway in macrophages via TLRs 3 and 4; (ii) a MyD88-dependent pathway in plasmacytoid dendritic cells (pDCs) via TLRs 7/8 and 9; and (iii) an intracellular recognition pathway utilizing the cytoplasmic receptors RIG-I/MDA5. Interestingly, these viral recognition pathways converge on TRAF3, which induces interferon through the activation of IRF3 or IRF7 by the TBK-1 and IKKi complexes. While type I IFN has been traditionally associated with antiviral responses, recent studies have demonstrated that many bacteria also induce type I interferon responses. The mechanisms of type I IFN induction and its role in host defense, however, are largely unclear. Studies with the Gram-positive intracellular bacterium Listeria monocytogenes indicated that it may trigger type I IFN induction through novel TLR-independent intracellular receptors and type I IFN may play a detrimental role to host response against listerial infection. In this article, we summarize some of these findings and discuss the functional differences of type I IFNs in bacterial and viral infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953977     DOI: 10.1179/096805106X118799

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  19 in total

1.  A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus.

Authors:  Zaida G Ramirez-Ortiz; Chrono K Lee; Jennifer P Wang; Louis Boon; Charles A Specht; Stuart M Levitz
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

2.  Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with Listeria monocytogenes.

Authors:  Kristina L Brzoza-Lewis; J Jason Hoth; Elizabeth M Hiltbold
Journal:  Cell Immunol       Date:  2011-12-06       Impact factor: 4.868

Review 3.  Inborn errors of anti-viral interferon immunity in humans.

Authors:  Vanessa Sancho-Shimizu; Rebeca Perez de Diego; Emmanuelle Jouanguy; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

4.  Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β.

Authors:  Catherine E Gleason; Alban Ordureau; Robert Gourlay; J Simon C Arthur; Philip Cohen
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

5.  Interleukin (IL)-21-independent pathogen-specific CD8+ T-cell expansion, and IL-21-dependent suppression of CD4+ T-cell IL-17 production.

Authors:  James M Ertelt; Tanner M Johanns; Jared H Rowe; Sing Sing Way
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

6.  Innate immune recognition of Yersinia pseudotuberculosis type III secretion.

Authors:  Victoria Auerbuch; Douglas T Golenbock; Ralph R Isberg
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

7.  Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection.

Authors:  Jamel Mankouri; Rennos Fragkoudis; Kathryn H Richards; Laura F Wetherill; Mark Harris; Alain Kohl; Richard M Elliott; Andrew Macdonald
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

8.  Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes.

Authors:  Tongmin Wang; Luqiu Chen; Emily Ahmed; Lianli Ma; Dengping Yin; Ping Zhou; Jikun Shen; Honglin Xu; Chyung-Ru Wang; Maria-Luisa Alegre; Anita S Chong
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

9.  SHIP prevents lipopolysaccharide from triggering an antiviral response in mice.

Authors:  Laura M Sly; Melisa J Hamilton; Etsushi Kuroda; Victor W Ho; Frann L Antignano; Stephanie L Omeis; Christina J van Netten-Thomas; Dana Wong; Hayley K Brugger; Olusegun Williams; Morris E Feldman; Benjamin T Houseman; Dorothea Fiedler; Kevan M Shokat; Gerald Krystal
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

10.  TRAF3: a novel tumor suppressor gene in macrophages.

Authors:  Almin I Lalani; Chang Luo; Yeming Han; Ping Xie
Journal:  Macrophage (Houst)       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.